Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is compare the effects of simvastatin+ezetimibe with those of
simvastatin alone on platelet activity, platelet-leukocyte interactions and inflammatory
variables in diabetic patients with or without impaired renal function.
Phase:
Phase 4
Details
Lead Sponsor:
Karolinska Institutet Karolinska University Hospital
Collaborator:
Danderyd Hospital
Treatments:
Ezetimibe Ezetimibe, Simvastatin Drug Combination Simvastatin